Country reports EU 1950-2015
June 11, 2019
Budapest, 12th June 2019
The Report “Cancer, Cardiovascular Disease, Diabetes and Chronic Obstructive Pulmonary Disease in Europe, 1950-2015” has been presented at the Ministerial Meeting in Budapest (Hungary).
Chronic diseases such as Cancer, Cardiovascular Disease (CVD), Diabetes and Chronic Obstructive Pulmonary Disease (COPD) are major causes of disability and premature deaths throughout Europe. These diseases are chronic in that once diagnosed they last for the patient’s lifetime with associated economic implications for the state. At the macro-level, life expectancy and healthy life expectancy in Central and Eastern Europe (new European Union Member States) lag behind that in the original European Union (EU) Member States. These differences have important implications for economic development.
Mortality rates from all forms of cancer are higher in the new EU Member States. The decline in mortality in men in the new EU Member States started around the year 2000, 15-20 years after the declines observed in the original EU Member States.
There have been remarkable declines in mortality from cardiovascular disease although death rates remain higher in new EU Member States. Rates are now lower than they were in 1950. There have been remarkable declines in mortality from myocardial infarction. Mortality from COPD has declinedin all countries since data became available in 1980. Mortality from diabetes is difficult to interpret since many deaths are attributed to other conditions which have been caused by diabetes.
Lung cancer mortality is declining in men and increasing in women throughout Europe, with higher rates in new EU Member States. Mortality from breast cancer is declining throughout Europe. There have been remarkable declines in stomach cancer: there is no country in Europe where mortality from stomach cancer is increasing in either men or women. There are important differences in colorectal cancer mortality patterns in Europe. While mortality from colorectal cancer has been declining steadily in both men and women in original EU Member States, in the new EU Member States mortality from colorectal cancer has increased. Declines in mortality rates for haematological malignancies have taken place since the year 2000.
There are differences which persist in the health of the populations in Europe. Mortality from major chronic diseases has been falling throughout Europe, although declines have occurred 10-20 years later in new EU Member States. The differences in mortality from colorectal cancer and the increasing rates in the new EU Member States deserve priority action. Steps must be taken to identify the causes of such differences and to implement policy to counteract this situation.
The International Prevention Research Institute made available all country reports (in PDF).
These reports should be cited as follows:
Boyle P, Dragomir M, and Pizot C. Cancer, Cardiovascular Disease, Diabetes and Chronic Obstructive Pulmonary Disease in Europe, 1950-2015. iPRI Technical Report 2019-01, International Prevention Research Institute, Lyon, France (2019).